ANTONAZZO, IPPAZIO COSIMO
 Distribuzione geografica
Continente #
AS - Asia 5.652
NA - Nord America 3.970
EU - Europa 3.069
SA - Sud America 745
AF - Africa 140
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 13.585
Nazione #
US - Stati Uniti d'America 3.831
SG - Singapore 1.878
VN - Vietnam 1.182
IT - Italia 1.028
CN - Cina 902
HK - Hong Kong 805
RU - Federazione Russa 602
BR - Brasile 546
DE - Germania 390
IE - Irlanda 205
FR - Francia 192
IN - India 151
KR - Corea 146
GB - Regno Unito 135
SE - Svezia 121
ID - Indonesia 114
BD - Bangladesh 93
FI - Finlandia 79
AR - Argentina 77
NL - Olanda 75
CA - Canada 64
IQ - Iraq 61
ZA - Sudafrica 51
MX - Messico 45
TR - Turchia 41
ES - Italia 40
PH - Filippine 36
PL - Polonia 35
SA - Arabia Saudita 35
AT - Austria 34
JP - Giappone 34
CO - Colombia 30
PK - Pakistan 30
UA - Ucraina 29
EC - Ecuador 28
VE - Venezuela 22
CH - Svizzera 21
MY - Malesia 19
EG - Egitto 18
MA - Marocco 17
UZ - Uzbekistan 17
AL - Albania 14
CL - Cile 14
CZ - Repubblica Ceca 14
AE - Emirati Arabi Uniti 13
IR - Iran 13
TN - Tunisia 13
KE - Kenya 11
ET - Etiopia 10
IL - Israele 9
PY - Paraguay 9
JO - Giordania 8
NP - Nepal 8
UY - Uruguay 8
AU - Australia 7
TW - Taiwan 7
DZ - Algeria 6
JM - Giamaica 6
KZ - Kazakistan 6
PT - Portogallo 6
QA - Qatar 6
CR - Costa Rica 5
DO - Repubblica Dominicana 5
LT - Lituania 5
OM - Oman 5
PA - Panama 5
PE - Perù 5
BE - Belgio 4
BO - Bolivia 4
HN - Honduras 4
MD - Moldavia 4
MN - Mongolia 4
PS - Palestinian Territory 4
RO - Romania 4
TH - Thailandia 4
BG - Bulgaria 3
BH - Bahrain 3
BY - Bielorussia 3
DK - Danimarca 3
KG - Kirghizistan 3
LB - Libano 3
LU - Lussemburgo 3
LV - Lettonia 3
RS - Serbia 3
AM - Armenia 2
AZ - Azerbaigian 2
BW - Botswana 2
CG - Congo 2
GR - Grecia 2
GT - Guatemala 2
GY - Guiana 2
HR - Croazia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
MK - Macedonia 2
MU - Mauritius 2
NG - Nigeria 2
NO - Norvegia 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 13.568
Città #
Singapore 1.117
Hong Kong 789
Ashburn 465
San Jose 456
Ho Chi Minh City 363
Ann Arbor 345
Hanoi 322
Hefei 277
Milan 254
Frankfurt am Main 213
Dublin 195
Dallas 173
New York 167
Seoul 140
The Dalles 135
Los Angeles 131
Chicago 128
Chandler 125
Santa Clara 118
Beijing 102
Lauterbourg 78
Jakarta 75
São Paulo 71
Munich 63
Rome 61
Moscow 60
Buffalo 55
London 50
Helsinki 49
Nuremberg 43
Fairfield 42
Princeton 40
Seattle 40
Da Nang 38
Boardman 37
Bologna 37
Council Bluffs 37
Haiphong 33
Wilmington 32
Ha Long 31
Tokyo 30
Baghdad 28
Rio de Janeiro 27
Thái Nguyên 26
Warsaw 26
Altamura 25
Biên Hòa 25
Verona 25
Houston 23
Ninh Bình 23
Orem 23
Perugia 23
Shanghai 23
Can Tho 22
Parma 21
Chennai 20
Toronto 20
Washington 20
Johannesburg 19
Florence 18
Lappeenranta 18
Lawrence 18
Salt Lake City 18
Mexico City 17
Turin 17
Woodbridge 17
Jeddah 16
Quận Bình Thạnh 16
Zurich 16
Brooklyn 15
Denver 15
San Diego 15
Tashkent 15
Dhaka 14
Hải Dương 14
Naples 14
Osasco 14
Phoenix 14
Roubaix 14
Vienna 14
Atlanta 13
Cambridge 13
Guangzhou 13
Montreal 13
Mumbai 13
Hangzhou 12
Kent 12
Palermo 12
Stockholm 12
Amsterdam 11
Bắc Giang 11
Bắc Ninh 11
New Delhi 11
Phủ Lý 11
Redondo Beach 11
Tirana 11
Turku 11
Curitiba 10
Elk Grove Village 10
Hyderabad 10
Totale 7.996
Nome #
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 549
Epidemiology of SLE in Italy: an observational study using a primary care database 542
Costs and effects of cardiovascular risk reclassification using the ankle-brachial index (ABI) in addition to the Framingham risk scoring in women 465
Health and economic impact of dapagliflozin for type 2 diabetes patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian general practitioners setting: a budget impact analysis 355
Incidence and risk factors for falls among nursing home residents in Italy: a retrospective cohort study 331
Knowledge, Attitudes and Practices Survey of Recombinant Zoster Vaccine among Cardiologists and Cardiac Nurses in Italy 312
Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019 272
Time-Trends in Air Pollution Impact on Health in Italy, 1990–2019: An Analysis From the Global Burden of Disease Study 2019 268
Azithromycin use and outcomes in patients with COVID-19: an observational real-world study 258
Treatment patterns in essential tremor: Real-world evidence from a United Kingdom and France primary care database 241
Farmacoutilizzazione della terapia per la gestione del paziente con tremore essenziale: uno studio di coorte retrospettivo condotto utilizzando i database dei medici di medicina generale di Regno unito e Francia 234
COVID-19 outbreak impact on anticoagulants utilization: an interrupted time-series analysis using healthcare administrative databases 234
Azithromycin use and covid-19: a real-world observational study. 232
Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database 227
PCSK9 Inhibitors’ New Users: Analysis of Prescription Patterns and Patients’ Characteristics from an Italian Real-world Study 227
Haemophilia management and treatment: An Italian survey on patients’, caregivers’ and clinicians’ point of view 223
Antidepressants Drug Use during COVID-19 Waves in the Tuscan General Population: An Interrupted Time-Series Analysis 221
Patterns and trends of idarucizumab use in an Italian region: a probabilistic record-linkage approach in a real-life setting 219
COVID-19 e suicidio: uno studio retrospettivo sul territorio di Bergamo e provincia 215
A Cross-Indication Budget Impact Model of Secukinumab for the Treatment of Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis in Italy 213
Statins Use in Patients with Cardiovascular Diseases and COVID-19 Outcomes: An Italian Population-Based Cohort Study 205
Real-World Clinical Outcomes and Replacement Factor VIII Consumption in Patients with Haemophilia A in Italy: A Comparison between Prophylaxis Pre and Post Octocog Alfa (BAY 81-8973) 203
Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression 198
Il carico di malattia associato ai virus dell'epatite B e C in Europa. Dati dal Global Burden of Disease Study 2019 198
Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: An Updated Systematic Literature Review 197
Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019 195
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up 195
The Value of Tucatinib in Metastatic HER2-Positive Breast Cancer Patients: An Italian Cost-Effectiveness Analysis 194
Association between azithromycin use and clinical outcomes in COVID-19 patients: an Italian observational study 193
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study 193
Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy 193
The psychosocial impact of haemophilia from patients’ and caregivers’ point of view: The results of an Italian survey 179
Patterns and trends of idarucizumab use in an Italian region: A probabilistic record-linkage approach in a real-life setting 178
Valutazione della prognosi nei soggetti ospedalizzati con COVID-19 in relazione all’utilizzo pregresso di statine: uno studio osservazionale condotto nelle ATS di Bergamo e Brescia 173
Valutazione dell’impatto della pandemia sugli accessi al sistema sanitario nei territori di Bergamo e Brescia 172
Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients 171
Risk management and drug utilization research 167
A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy 167
Analisi della variazione del burden dell’inquinamento atmosferico in Italia dal 1990 al 2019: evidenze dai dati del Global Burden of Disease Study 165
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 162
Impact of covid-19 lockdown, during the two waves, on drug use and emergency department access in people with epilepsy: An interrupted time-series analysis 153
A Multidatabase study of trajectories of antidepressant use in Italy 148
Respiratory Syncytial Virus (RSV) and Intention to Recommend RSV Vaccination: A Cross-Sectional Survey of Cardiologists and Cardiac Nurses in Southern Italy 147
The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study 146
Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019 141
Does smoking have an impact on the immunological response to COVID-19 vaccines? Evidence from the VASCO study and need for further studies 136
Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1 134
Time trends in the incidence of essential tremor: Evidences from UK and France primary care data 131
Impatto dell’epidemia SARS-COV2 sulla gestione dei pazienti affetti da epilessia: un’analisi delle serie storiche interrotte sull’uso degli antiepilettici e l’accesso in pronto soccorso durante le due ondate COVID-19 126
Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region 125
Raphanus sativus cv. Sango sprout juice decreases diet-induced obesity in sprague dawley rats and ameliorates related disorders 121
Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug–drug interactions through the FDA adverse event reporting system 121
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up—Reply 114
Prevalence and determinants of long-term utilization of antidepressant drugs: A retrospective cohort study 113
Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems 107
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping 106
Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months 104
Human papillomavirus vaccine and demyelinating diseases—A systematic review and meta-analysis 103
Assessing intravitreal anti-VEGF drug safety using real-world data: methodological challenges in observational research 102
Use of antidepressants and the risk of Parkinson's disease in the Local Health Trust of Bologna: A historical cohort study 100
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System 100
Drug-induced Kounis syndrome: A matter of pharmacovigilance 99
The Burden of Chronic Heart Failure in Primary Care in Italy 99
Digestibility, toxicity and metabolic effects of rapeseed and sunflower protein hydrolysates in mice 98
Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting System 98
Diabetes is associated with decreased migraine risk: A nationwide cohort study 97
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System 96
Use of antidepressants during COVID19 outbreak: a real-world drug-utilization study 95
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System 94
Signal of potentially protective drug–drug interactions from spontaneous reporting systems: proceed with caution 93
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy 93
Editorial: Overcoming boundaries in public health: Advances in international and global health 91
Adverse events with sacubitril/valsartan in the real world: Emerging signals to target preventive strategies from the FDA adverse event reporting system 88
Real-world evidence and pharmacovigilance: workshop of the Italian Epidemiological Association and of the Italian Society of Pharmacology 87
Hepatitis B vaccination and the putative risk of central demyelinating diseases – A systematic review and meta-analysis 83
Reply-Letter to the editor - The valuable support of spontaneous reporting systems in exploring safety profile of dietary supplements 82
Drug-induced systemic lupus erythematosus: Should immune checkpoint inhibitors be added to the evolving list? 80
Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018 78
Timing of hepatitis B and C virus elimination in Europe: a picture from the Global Burden of Disease Study 2019 75
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System 73
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres 73
Totale 13.886
Categoria #
all - tutte 50.410
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.410


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202175 0 0 0 0 0 0 0 0 0 0 30 45
2021/2022451 51 44 42 39 49 20 46 23 21 32 37 47
2022/2023834 44 211 69 45 71 72 158 39 41 25 24 35
2023/20241.358 42 80 71 123 162 262 139 64 127 44 105 139
2024/20253.445 173 332 133 189 287 180 249 120 368 490 328 596
2025/20267.459 1.310 790 581 878 816 398 1.108 324 569 637 48 0
Totale 13.886